Gazing into crystal balls is beyond the expertise of most scientists. Yet, as we look further into the 21st century, one does not have to be Nostradamus to predict that the current genomics and proteomics "revolution" will have an immense impact on medical bacteriology. This impact is already being re- ized in many academic departments, and although encroachment on routine diagnostic bacteriology, particularly in the hospital setting, is likely to occur at a slower pace, it remains nonetheless inevitable. Therefore, it is ...
Read More
Gazing into crystal balls is beyond the expertise of most scientists. Yet, as we look further into the 21st century, one does not have to be Nostradamus to predict that the current genomics and proteomics "revolution" will have an immense impact on medical bacteriology. This impact is already being re- ized in many academic departments, and although encroachment on routine diagnostic bacteriology, particularly in the hospital setting, is likely to occur at a slower pace, it remains nonetheless inevitable. Therefore, it is important that no one working in bacteriology should find themselves distanced from these fundamental developments. The involvement of all clinical bacteriologists is essential if the significant achievements of genome sequencing and analysis are to be turned into tangible advances, with resulting benefits for patient care and m- agement. It is our hope that Genomics, Proteomics, and Clinical Bacteriology: Methods and Reviews will play a part in bringing such a development to fruition. The advances in genomics and proteomics have already given us frequent opportunities to reassess our knowledge and understanding of established b- terial adversaries, and have provided us with the means to identify new foes. The new knowledge gained is enabling us to reconsider, for example, our c- cepts of bacterial pathogenicity, phylogeny and novel targets for antibacterial chemotherapy. These topics, and others, are considered in Genomics, Proteomics, and Clinical Bacteriology: Methods and Reviews.
Read Less
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
Very Good. Very Good condition. Volume 266. A copy that may have a few cosmetic defects. May also contain a few markings such as an owner's name, short gifter's inscription or light stamp.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
Very good. No dust jacket. Ex-library. Sewn binding. Cloth over boards. 395 p. Contains: Unspecified. Methods in Molecular Biology, 266. Audience: General/trade. LCCN 2004000332 Type of material Book Main title Genomics, proteomics, and clinical bacteriology: methods and reviews / edited by Neil Woodford and Alan Johnson. Published/Created Totowa, N.J. : Humana Press, c2004. Description x, 395 p. : ill.; 24 cm. ISBN 1588292185 (alk. paper) LC classification QR74. G46 2004 Related names Woodford, Neil. Johnson, Alan P. (Alan Patrick), 1951-Subjects Molecular microbiology. Bacterial genetics. Genomics. Proteomics. Diagnostic bacteriology. Genomics--methods. Bacteriological Techniques--methods. Proteomics--methods. Notes Includes bibliographical references and index. Series Methods in molecular biology; 266 Methods in molecular biology (Clifton, N.J. ); v. 266. Dewey class no. 616.9/201 NLM class no. W1 ME9616J v.266 2004 QU 58.5 G3355 2004 Other system no. (DNLM)101202667
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
Fine. Books In Good Condition. May Have a Small Publisher Mark. Ship Via Fedex. Shipping Time 7 To 10 Days. Bookseller With Over 20 Years In Book Trade.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
Fine. 8vo, hardcover. No dj, as issued. As new condition. Bright, crisp & clean, unread; covers glossy. Few very faint outer smudges from storage. x, 395 p., illus.
